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Targeting CCR5 is a valid strategy for microbicide devel-
opment. PSC-RANTES, a chemically modified variant of
one the natural protein ligands of CCR5, is a potent HIV
entry inhibitor that has shown significant activity in a
macaque vaginal challenge model. PSC-RANTES itself is
unlikely to be developed for clinical use as a microbicide,
however, since (i) the production costs are likely to be too
high for it to meet the needs of developing countries, and
(ii) it strongly activates CCR5; if long-term use were to
give rise to pro-inflammatory effects, this could counter-
balance its inhibitory activities against HIV acquisition.
We have been using an innovative phage display
approach to discover novel, potent, fully recombinant
RANTES analogues which could be produced entirely by
biosynthesis, and thus at a much lower cost than PSC-
RANTES. The resulting molecules have been tested in vitro
for anti-HIV potency, as well as their capacity to activate
CCR5.
Among the new molecules that we have identified and
tested is 5P12-RANTES, which (i) has comparable potency
to PSC-RANTES in all tests conducted so far (ii) contains
only natural amino acids and could therefore be produced
could be produced entirely by biosynthesis, and (iii) has
no detectable signaling activity on CCR5.
Highly potent, fully recombinant RANTES analogues such
as 5P12-RANTES represent promising candidates for
development as microbicides.
from 2006 International Meeting of The Institute of Human Virology
Baltimore, USA. 17–21 November, 2006
Published: 21 December 2006
Retrovirology 2006, 3(Suppl 1):S52 doi:10.1186/1742-4690-3-S1-S52
<supplement> <title> <p>2006 International Meeting of The Institute of Human Virology</p> </title> <note>Meeting abstracts. A single PDF containing all abstracts in this Supplement is available <a href=" http://www.biomedcentral.com/content/files/pdf/1742-4690-3-S1-full.pdf ">here</a></note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-3-S1-info.pdf</url></supplement>
© 2006 Hartley; licensee BioMed Central Ltd. 